Dr Ling Zhu
People_

Dr Ling Zhu

Senior Research Fellow
Save Sight Institute
Faculty of Medicine and Health
Dr Ling Zhu

Dr Ling Zhu obtained his PhD from the Department of Biochemistry, Rutgers (USA) in 2008 and joined the Macula Research Group in Save Sight Institute to continue his career at the interface of clinical and basic research. He is now the head of the lab unit leading one postdoc, two research assistants and one HDR student. Dr Zhu has established a diverse array of techniques, which have greatly facilitated several projects in studying the cellular and molecular pathogenesis of debilitating retinal diseases such as diabetic retinopathy, age-related macular degeneration and macular telangiectasia type 2. He successfully attracted more than 2M dollars of research funding in the past five years. Dr Zhu has broad knowledge and well-established skills in Biochemistry and Molecular biology. He has established human retinal explants, which is the unique ex vivo model required in the proposed study. Dr Zhu has a career total of 93 publications, 40 within the past five years, with 3590 citations, H-index 34 (14 years post-PhD). Dr Zhu is the major author of most of these papers published in the leading journals in the field, such as eLife and Ophthalmology.

Human retinal explant culture; Macula; Nanomedicine in ophthalmology

  1. Preclinical study of delivering RNA-LNPs to treat retinal degeneration
  2. Targeting retinal metabolism to treat macular diseases
  3. Targeting human Muller cells to prevent retinal fibrosis
  4. Macula-on-a-Chip: a novel drug screen and development platform.
Project titleResearch student
Diversity of Amacrine Cells in the RetinaAlyssa Kristina BALDICANO
NRF2/MAFF RNA-based drug delivered by lipid nanoparticles for treating macular degenerationJialing ZHANG

Publications

Download citations: PDF; RTF; Endnote

Selected Grants

2023

  • Rewarding Research 2024, Zhu L, Faculty of Medicine and Health/FMH Rewarding Research Success
  • Targeting the glucose-alanine cycle to treat retinal diseases, Zhang B, Gillies M, Zhu L, Australian Vision Research (AVR)/Australian Vision Research Grants

2022

  • Targeting Nrf2-MAFF pathway in Mller cells to treat macula degeneration, Zhu L, Gilles M, Zhang T, Ophthalmic Research Institute of Australia (ORIA)/ORIA Grant